Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

PDC*line Pharma, a clinical-stage biotech company developing a new class of immunotherapies for cancers, presented the ...

Osmotic Pumps Market. The global osmotic pumps market is set for substantial growth, with revenue projected to rise from USD ...

ADMA Biologics ADMA is witnessing a phenomenal run this year. Its shares have skyrocketed 320.6% year to date against the ...

Elizabeth A. Brem, MD, an assistant clinical professor in the Division of Hematology/Oncology, School of Medicine at the University of California, Irvine, discusses multiple types of therapies used in ...

Attorney General Kris Mayes took the first steps Friday to putting convicted murderer Aaron Gunches to death. Mayes asked the ...

ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patientsNew analysis from the IMROZ phase 3 ...

Roche’s Lunsumio may be the first CD20xCD3 T-cell engager approved by the FDA, but intravenous administration puts the drug ...

It is a serious mistake for Arizona to restart the machinery of death and for other states to cling to capital punishment.

It is a serious mistake for Arizona to restart the machinery of death and for other states to cling to capital punishment.

Merck's ovarian cancer trial met its primary endpoint, while lymphoma trial data set the Phase 3 dose for zilovertamab ...